Ntinib 200 Capsule 30's belongs to the class of anticancer drugs called tyrosine kinase inhibitors used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Ph+ CML is a type of blood cancer that causes white blood cells to behave differently.

Ntinib 200 Capsule 30's contains Nilotinib which works by blocking the action of an abnormal protein (Bcr-Abl tyrosine kinase) produced by an abnormal Philadelphia chromosome that signals abnormal white blood cells (cancerous cells) to multiply. Thereby, it stops the multiplication and inhibits the growth of cancerous cells and then causes the death of these cells.

Take Ntinib 200 Capsule 30's as prescribed. You are recommended to take Ntinib 200 Capsule 30's for as long as your doctor has advised it for you based on your medical condition. Sometimes, Ntinib 200 Capsule 30's may cause common side effects such as vomiting, nausea, diarrhoea, headache, constipation, tiredness, and muscle and joint pain. Most of these side effects of Ntinib 200 Capsule 30's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Nilotinib or any other medicines, please tell your doctor. Avoid taking Ntinib 200 Capsule 30's if you are pregnant or breastfeeding. You are recommended to use effective contraceptive methods while taking Ntinib 200 Capsule 30's and for two weeks after completing the course of Ntinib 200 Capsule 30's. Ntinib 200 Capsule 30's is not recommended for children below one year of age. Drive only if you are alert as Ntinib 200 Capsule 30's may cause dizziness or visual disorders as side effects in some people. If you have yellow skin and eyes, dark-coloured urine, or stomach pain while taking Ntinib 200 Capsule 30's, contact your doctor immediately, as these might be symptoms of liver problems. 

Ntinib 200 Capsule 30's is used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). The detailed uses of Ntinib 200 Capsule 30's are as follows:

• Treats Ph+ CML: Ntinib 200 Capsule 30's targets and slows the growth of cancerous white blood cells in patients with this specific type of leukemia.
• Helps achieve remission: Ntinib 200 Capsule 30's reduces the number of abnormal cells in the blood and bone marrow, helping control the disease.
• Lowers the risk of disease progression: Ntinib 200 Capsule 30's helps prevent the leukemia from advancing to more aggressive stages.

• Ntinib 200 Capsule 30's should be taken on an empty stomach, at least 2 hours before or 1 hour after eating food, or as advised by the doctor.
• Follow your doctor’s instructions on the dosage and timing of this medication to ensure safety.
• Swallow Ntinib 200 Capsule 30's as a whole with a glass of water.
• Do not chew, crush, or break it.

Ntinib 200 Capsule 30's contains Nilotinib, an anticancer drug used to treat Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). In chronic myeloid leukemia (CML) patients, a change in genetic material (DNA) triggers a signal that tells the body to produce more abnormal white blood cells (cancerous cells). Nilotinib works by blocking this signal and thus stops the production of cancerous cells. Ntinib 200 Capsule 30's is used in adults and children with newly diagnosed Ph+ CML in the chronic phase and in adults with Ph+ CML in the accelerated and chronic phase who did not tolerate or no longer benefit from other treatments, including Imatinib. 

If you are allergic to Nilotinib or any other medicines, please tell your doctor. Avoid taking Ntinib 200 Capsule 30's if you are pregnant or breastfeeding. You are recommended to use effective contraceptive methods while taking Ntinib 200 Capsule 30's and for two weeks after completing the course of Ntinib 200 Capsule 30's. Ntinib 200 Capsule 30's is not recommended for children below one year of age. Ntinib 200 Capsule 30's may affect the growth and development of children with chronic phase Ph+ CML. Some children and adolescents may have slower than normal growth while taking Ntinib 200 Capsule 30's. Therefore, your doctor will monitor the growth of your child at regular visits. Drive only if you are alert as Ntinib 200 Capsule 30's may cause dizziness or visual disorders as side effects in some people. Ntinib 200 Capsule 30's may increase the risk of liver problems, especially in people with a history of liver problems. Therefore, if you have yellow skin and eyes, dark-coloured urine, or stomach pain while taking Ntinib 200 Capsule 30's, contact your doctor immediately, as these might be symptoms of liver problems. Inform your doctor if you have a severe problem with lactose (milk sugar) or other sugars as Ntinib 200 Capsule 30's may contain lactose. Most people who have mild or moderate lactose intolerance can take Ntinib 200 Capsule 30's. Avoid taking Ntinib 200 Capsule 30's if you have low levels of magnesium or potassium in the blood or long QTc syndrome. If you have had a surgical procedure involving the removal of the entire stomach (total gastrectomy), inform your doctor before taking Ntinib 200 Capsule 30's.